Skip to main content

Rangwala Reshma

In the past year, 3 open-market sale filings worth $55.6K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$55.6K
3 filings
Net
−$55.6K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Rangwala Reshma as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

KPTI Karyopharm Therapeutics Inc.

EVP & Chief Medical Officer9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 15, 2026 (view filing)May 141 dayRangwala ReshmaEVP & Chief Medical OfficerSSale−408$9.50−$3.88K−0.7%56.8K after
Apr 22, 2026 (view filing)Apr 211 dayRangwala ReshmaEVP & Chief Medical OfficerSSale−449$8.94−$4.01K−0.8%56.3K after
Mar 3, 2026 (view filing)Mar 21 dayRangwala ReshmaEVP & Chief Medical OfficerSSale−5.07K$9.41−$47.7K−8.2%56.7K after
Sep 16, 2025 (view filing)Sep 151 dayRangwala ReshmaEVP & Chief Medical OfficerSSale−408$6.43−$2.62K−1.4%29.4K after
Apr 24, 2025 (view filing)Apr 231 dayRangwala ReshmaEVP & Chief Medical OfficerSSale−419$6.17−$2.59K−1.4%28.9K after
Mar 6, 2025 (view filing)Mar 42 daysRangwala ReshmaEVP & Chief Medical OfficerSSale−3.59K$6.29−$22.6K−10.9%29.3K after
Apr 23, 2024 (view filing)Apr 221 dayRangwala ReshmaEVP & Chief Medical OfficerSSale−6.79K$1.17−$7.94K−1.9%342.9K after
Mar 4, 2024 (view filing)Feb 29-Mar 14 daysRangwala ReshmaEVP & Chief Medical OfficerSSaleCommon−21.6K$1.18−$25.5K−5.8%349.7K after2 lots
Apr 24, 2023 (view filing)Apr 204 daysRangwala ReshmaEVP & Chief Medical OfficerSSale−6.77K$4.05−$27.4K−4.1%158.2K after2 lots10b5-1